Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ
JCM | Free Full-Text | Treatment of Giant Cell Arteritis (GCA)
How is Actemra® (tocilizumab) for GCA believed to work?
COVID-19 Clinical Trials Safety Side Effects | ACTEMRA® (tocilizumab)
Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis
SJIA Clinical Trial Safety Profile Side Effects | ACTEMRA® (tocilizumab)
Cutaneous Adverse Effects of Surface-Targeted Monoclonal Antibodies – Consult QD
Tocilizumab in patients with severe COVID-19: a retrospective cohort study - The Lancet Rheumatology
About ACTEMRA® (tocilizumab) Treatment Info for Healthcare Professionals
ACTEMRA (Tocilizumab) Dosage & Rx Info, Uses | ACTEMRA Side Effects - MPR
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
Side effects with Tocilizumab and suggested management. | Download Table
Pharmaceutics | Free Full-Text | Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial - The Lancet Rheumatology
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial - The Lancet Rheumatology
Frontiers | Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
PDF) Long-term effects of tocilizumab therapy for uveitic macular edema
Actemra Side Effects: Common, Severe, Long Term - Drugs.com
Actemra Side Effects: Common, Severe, Long Term - Drugs.com
Effects of long-term infliximab and tocilizumab treatment on anxiety-like behavior and cognitive function in naive rats | SpringerLink
Practice points for ophthalmologists from the 2020 British Society for Rheumatology Giant Cell Arteritis guidelines | Eye
Actemra Side Effects | Common and Rare Reactions to Actemra
PDF) Long-term treatment with tocilizumab in giant cell arteritis: Efficacy and safety in a monocentric cohort of patients
TOCILIZUMAB
GCA Clinical Trial Results | ACTEMRA® (tocilizumab)
Healthcare | Free Full-Text | Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial - The Lancet Rheumatology
Frontiers | Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
Hundreds died while taking an arthritis drug, but nobody alerted patients
Tocilizumab for relapsing and remitting giant cell arteritis: a case series | Journal of Medical Case Reports | Full Text
JCM | Free Full-Text | Steroid-Sparing Effect of Tocilizumab and Methotrexate in Patients with Polymyalgia Rheumatica: A Retrospective Cohort Study
